Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia

NCT00260689 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

136

Enrollment

NIH

Sponsor class

Conditions

Immunosuppresion
Thrombocytopenia
Pancytopenia
Neutropenia

Interventions

BIOLOGICAL: Anti-thymocyte globulin (rabbit)
BIOLOGICAL: Anti-thymocyte globulin (horse)
DRUG: Cyclosporine
DRUG: Alemtuzumab

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)